Patients with vitiligo had a threefold lower risk of developing melanoma or nonmelanoma skin cancer, according to a study of 1,307 patients with the skin condition and their partners. The findings appeared in the British Journal of Dermatology.
Vitiligo may lower skin cancer risk, study finds
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan